Prelude Therapeutics IncorporatedPRLD
Close of Friday, October 23, 2026 · Prelude Therapeutics Incorporated is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$3.63
vs its Pivot
-8.6%
OnlyAlpha Score
45
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -9.0% | +25.2% | +129.7% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| OrbiMed | 1.4% of holdings |
| RA Capital | 0.3% of holdings |
| Baker Bros. Advisors | 0.3% of holdings |
Get PRLD in your free daily emailAfter every close: whether PRLD is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track PRLD free → Full Stock check
Track PRLD free → Full Stock check